News

The active principal Proveblue is compliant with the monograph of the European pharmacopoeia and to ICH Q3A standards on impurities in new active substances. With is approval, Provepharm

ICON Cytometry Services’ full service solution allows clients to collaborate with the company at the early stages of development to create compound-specific assays. Clients work with ICON Central

INCIVEK is an oral medicine that acts directly on the hepatitis C virus protease, an enzyme essential for viral replication. The approval of INCIVEK was based on data

The company’s decision follows the approval from a Safety Review Committee which has evaluated the safety data from the first group of healthy subjects. The clinical trial protocol

At the new Indianapolis facility, Advion will focus on the earlier stage, drug discovery and metabolism bioanalytical services which evaluate how a potential new medicine is absorbed and

Brazil- based Vetec is a supplier of high quality specialty chemicals for the academic and industrial markets and provides products that support research, development and manufacturing. Vetec brings

Denosumab specifically targets RANK Ligand, an essential regulator of osteoclasts (the cells that break down bone). By targeting RANK Ligand regulator, denosumab has shown the ability to prevent

Nestle Health Science offers nutritional solutions for people with specific dietary needs related to illnesses, disease states or the special challenges of different life stages. With this acquisition,

Under the agreement, Valeant will acquire 87.2% of the outstanding shares of Sanitas, with at least 82.6% of the outstanding shares required to be delivered at closing. Sanitas